Developing
Tech·6/3/2026AI summary
FRONTEO's AI Aims to Accelerate Drug Discovery by Identifying Novel Target Molecules
FRONTEO is focusing on identifying target molecules for drug discovery using its AI engine "KIBIT," which analyzes論文 data to find unknown candidates. This accelerates a process that previously took years to mere days, addressing a key bottleneck in AI-driven drug development.
I
ITmedia